RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Iterum Therapeutics - Stock

Iterum Therapeutics Stocks 2024

Iterum Therapeutics Stocks

12.96 M

Ticker

ITRM

ISIN

IE00BF3W0Q35

WKN

A2JMZP

In 2024, Iterum Therapeutics had 12.96 M outstanding stocks, a 0% change from the 12.96 M stocks in the previous year.

The Iterum Therapeutics Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2029e12.96
2028e12.96
2027e12.96
2026e12.96
2025e12.96
2024e12.96
202312.96
202212.24
202110.89
20201.6
20190.97
20180.96
20170.88
20160.88

Iterum Therapeutics Aktienanalyse

What does Iterum Therapeutics do?

Iterum Therapeutics is an Irish biotechnology company that focuses on developing antibiotics for serious bacterial infections. The company was founded in 2015 and has since undergone several successful financing rounds. The business model of Iterum Therapeutics is based on the discovery, development, and commercialization of novel anti-infectives that specialize in hard-to-reach or resistant bacteria. The company has developed a strong pipeline of antibiotic products that aim to combat the growing threat of antibiotic resistance. Iterum Therapeutics operates in several sectors, including clinical development, manufacturing, and marketing of antibiotic products. The company collaborates with leading industry players to ensure the effectiveness and safety of its products. One of Iterum Therapeutics' products is Sulopenem, a novel antibiotic specifically developed for treating infections caused by various types of bacteria. Sulopenem has shown promise in clinical studies and has the potential to play a significant role in combating antibiotic resistance. In addition, Iterum Therapeutics is also developing other antibiotic products focusing on combating bacteria responsible for severe infections, including Pseudomonas aeruginosa and Enterobacteriaceae. Iterum Therapeutics has a strong research and development department that focuses on the discovery and development of new antibiotic products. The company works closely with leading universities and research institutions to build a strong pipeline of innovative anti-infectives. The products of Iterum Therapeutics have the potential to make a significant contribution to combating antibiotic resistance and serious infections. The company is committed to further advancing the growth of its pipeline and maximizing the potential of its products to improve the health of patients worldwide. Iterum Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Iterum Therapeutics's Shares Outstanding

Iterum Therapeutics's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Iterum Therapeutics’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Iterum Therapeutics’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Iterum Therapeutics’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Iterum Therapeutics Stock

How many stocks are there of Iterum Therapeutics?

The current number of stocks of Iterum Therapeutics is 12.96 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Iterum Therapeutics are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Iterum Therapeutics evolved in recent years?

The number of shares of Iterum Therapeutics has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Iterum Therapeutics as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Iterum Therapeutics?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Iterum Therapeutics pay?

Over the past 12 months, Iterum Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Iterum Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Iterum Therapeutics?

The current dividend yield of Iterum Therapeutics is .

When does Iterum Therapeutics pay dividends?

Iterum Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Iterum Therapeutics?

Iterum Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Iterum Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Iterum Therapeutics located?

Iterum Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Iterum Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Iterum Therapeutics from 6/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/11/2024.

When did Iterum Therapeutics pay the last dividend?

The last dividend was paid out on 6/11/2024.

What was the dividend of Iterum Therapeutics in the year 2023?

In the year 2023, Iterum Therapeutics distributed 0 USD as dividends.

In which currency does Iterum Therapeutics pay out the dividend?

The dividends of Iterum Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Iterum Therapeutics

Our stock analysis for Iterum Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Iterum Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.